Due to the Best-1 role in other pathological conditions, studies on a possible contribution to ALS will help understand whether it excessively releases glutamate or shifts to GABA release, clarifying whether its activity needs to be blocked or enhanced. This evidence concerns the gene BEST1 and amyotrophic lateral sclerosis.